Natera Email Format
Biotechnology ResearchTexas, United States5001-10000 Employees
Natera is a global biotechnology company focused on cell-free DNA and precision medicine, with core activity in oncology, women's health, and organ health. Its objective is to incorporate personalized genetic testing into standard care to enable earlier, more targeted interventions. Headquartered in Austin, Texas, Natera operates laboratories in Austin and San Carlos that hold ISO 13485 certification and CAP accreditation and are CLIA-certified, while its subsidiary Foresight Diagnostics runs an ISO 27001-certified, CAP-accredited CLIA-lab in Boulder. The company serves clinicians and health systems seeking molecular diagnostics to support risk assessment and treatment decisions. A notable 2026 development was a strategic collaboration with CytoDyn to study ctDNA dynamics in metastatic colorectal cancer. Its tests are backed by a substantial body of peer-reviewed publications, underscoring its role in the cell-free DNA and precision-medicine field.